Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |